Prescription Medicines & Medical Devices

The thesis

Own established manufacturers of prescription medicines and medical devices, whose demand depends on treatment needs rather than AI infrastructure spending. The technology drawdown makes this a timely diversification sleeve, while Lilly's reimbursement debate highlights the importance of balancing drug-volume growth with pricing risk. Device manufacturers broaden the basket beyond pharmaceutical pipelines, though reimbursement pressure and product execution remain risks.